These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18347258)

  • 41. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
    Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L1CAM-ILK-YAP Mechanotransduction Drives Proliferative Activity of Epithelial Cells in Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Kojima H
    Am J Pathol; 2020 Aug; 190(8):1667-1679. PubMed ID: 32360569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of IL-17 and its role in bone destruction in human middle ear cholesteatoma.
    Haruyama T; Furukawa M; Kusunoki T; Onoda J; Ikeda K
    ORL J Otorhinolaryngol Relat Spec; 2010; 72(6):325-31. PubMed ID: 20847582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
    Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
    Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
    Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The functional and anatomical results of the canal wall down tympanoplasty in extensive cholesteatoma.
    Aslan Felek S; Islam A; Celik H; Demirci M; Samim E; Kose SK
    Acta Otolaryngol; 2009 Dec; 129(12):1388-94. PubMed ID: 19922086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
    Liu D; Ma X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
    Durko M; Kaczmarczyk D
    Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
    Sudhoff H; Dazert S; Gonzales AM; Borkowski G; Park SY; Baird A; Hildmann H; Ryan AF
    Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.
    Sudhoff H; Tos M
    Am J Otol; 2000 Nov; 21(6):786-92. PubMed ID: 11078064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using surgical observations of ossicular erosion patterns to characterize cholesteatoma growth.
    Maresh A; Martins OF; Victor JD; Selesnick SH
    Otol Neurotol; 2011 Oct; 32(8):1239-42. PubMed ID: 21921854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Computed tomography (CT) of the temporal bone in diagnosis of acquired cholesteatoma of the middle ear].
    Zelikovich EI
    Vestn Otorinolaringol; 2004; (5):28-32. PubMed ID: 15602483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
    Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma.
    Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H
    Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
    Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversibility of experimental cholesteatoma epithelium using Mongolian gerbils.
    Park K; Choung YH; Chun YM; Lee JS; Hong SP
    Acta Otolaryngol; 2005 May; 125(5):540-6. PubMed ID: 16092548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.